Fredun Pharmaceuticals Ltd (fredun) Financial Research

Fredun Pharmaceuticals is a Mumbai-based pharmaceutical company focused on manufacturing and marketing branded generic formulations and active pharmaceutical ingredients. Its therapeutic portfolio spans anti-infectives, gastrointestinal, and pain management segments, supplied to both domestic and export markets. The company operates its own manufacturing facilities and sells through a network of retail and institutional channels.

Current Price: INR 1495.0

Price Change: 0.46%

- Fredun Pharmaceuticals Ltd. Share Price Rise and Valuation (Source: Univest - 13 Aug 2026) - Fredun Pharmaceuticals board approves 2:1 bonus issue (Source: The Economic Times - 26 May 2026) - Fredun Pharmaceuticals fixes June 23 record date for 7% final dividend (Source: scanx.trade - 23 Jun 2026) - Bonus issue alert! Last day to buy this microcap pharma stock that rallied 200% in one year (Source: The Economic Times - 15 Jul 2026) - Fredun Pharmaceuticals Reschedules Investor Meeting to March 25, 2026 Virtual Format (Source: scanx.trade - 18 Mar 2026)